15.02.2010 • News

DSM Announces Management Changes

DSM has announced the following management changes: Mauricio Adade, currently president, Human Nutrition & Health (HNH) of DSM Nutritional Products, has been appointed chief marketing officer (CMO) as of May 1. In this position he will report to Stephan Tanda, member of the DSM Managing Board. Mauricio Adade, a Brazilian national, began his career with Roche in 1988 and has held positions in Marketing in Sao Paulo, Mexico and Singapore before moving to Switzerland. He has recently been the head of global marketing for DNP and in 2006 became the Business Group Director Human Nutrition and Health.

Rick Greubel,currently group vice president and international president at Tyson Foods, will succeed Mauricio Adade as President HNH of DSM Nutritional Products as of May 1. He will report to Leendert Staal, president and CEO of DSM Nutritional Products.Rick Greubel, an American national, is highly experienced in the food industry, through his latest position and has built a long standing career in general management and marketing positions with his previous employer Monsanto all over the world. His track record in the food industry, building large businesses and realizing significant growth in emerging markets gives him an excellent starting position to positively impact DSM Nutritional Products.

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read